Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
International Journal of Cancer|December 15, 1990
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoidsG Scambia, F O Ranelletti, P Benedetti Panici, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
International Journal of Cancer|May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell linesG Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
British Journal of Haematology|December 1, 1991
Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitorsL M Larocca, L Teofili, G Leone, et al.
British Journal of Cancer|September 1, 1996
Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancerR Meazza, S Marciano, S Sforzini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1994
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cellsM Ferrantini, M Giovarelli, A Modesti, et al.
The Journal of General Virology|October 1, 1994
Defective response to T cell mitogens in mice injected with human immunodeficiency virus type 1-infected U937 cellsC M Ausiello, P Sestili, C Locardi, et al.
The Journal of Experimental Medicine|October 1, 1996
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient miceI Screpanti, P Musiani, D Bellavia, et al.
Human Gene Therapy|January 1, 1996
Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovirL Santodonato, M Ferrantini, L Gabriele, et al.
Pageof 21